In co-culture conditions, this microglia/macrophage death acts in a paracrine fashion to kill sensitive GBM cells, conferring LCL161 monotherapeutic efficacy in the absence of exogenous TNF-α. The gene discussed is TNF; the disease is glioblastoma.